Humanity Free From Age-Related Diseases
Elena has been a longevity activist and advocate since 2013, when she first started to organize educational events to make new evidence-based methods of healthy life extension more popular. The last few years have seen Elena leading some successful projects in Russia, aimed at spreading the idea of healthy longevity among decision makers as well as the general public.
Tina Woods is a social entrepreneur who brings diverse stakeholders together to address the system changes needed to improve health for all. She is the Founder and CEO of Collider Health and works with the private sector and public sector, including the National AHSN AI Network, NHSX AI Lab, and UK Research & Innovation on the Healthy Ageing Industrial Strategy Challenge Fund.
Didier Coeurnelle is an active member of the European Life Extension Community. He is a funding member and co-chair of Heales, the Healthy Life Extension Society, and is a member of the board of the Association Française Transhumaniste (AFT) Technoprog. Didier is also a Board Member of the International Longevity Alliance.
Alexandra has dedicated her scientific career to the understanding and development of rejuvenation biology. She holds a PhD from Humboldt University Berlin for her work on degradation of damaged proteins by aged microglia, and received her Habilitierung (Professorial Qualification) at the University of Leipzig, Germany for her thesis “Modification of aging in mesenchymal stem cells”.
Dr. Kris Verburgh is a medical doctor and an expert in aging and longevity, and in new developments in medicine and biotechnology. He is a researcher at the Free University of Brussels, and faculty member at Singularity University Benelux, where he teaches about the future of medicine and longevity.
Sebastian A. Brunemeier
Sebastian A. Brunemeier is a biotech founder and VC investor. He is CEO and Co-Founder of ImmuneAGE Pharma, a stealth-mode company developing small molecules for immune rejuvenation. Previously, he was Co-Founder and Chief Investment Officer at Cambrian Biopharma and a Principal at Apollo Health Ventures, the first and largest aging-focused venture capital fund in the world.
After mass consumer success building the largest dating site (Badoo) and consumer VPN (AnchorFree) in the world, Michael, motivated by seeing family members encounter tragic health outcomes, joined forces with his Co-Founder Peter Ward to collaborate with longevity scientists to bring predictive health monitoring and longevity interventions directly to consumers to increase their healthspans. Their service Humanity is currently in private testing with thousands on the waiting list to join.
Hannah Went attended the University of Kentucky and graduated with a degree in Biology. During that time, she had multiple research internships at the University of Kentucky studying cell signaling and cell biology. After graduation, she worked for the International Peptide Society as their Director of Content and Research.
Peter Fedichev is a scientist and biotech entrepreneur. His scientific background lies in the field of condensed matter physics, biophysics and bioinformatics. Peter earned M.S. in theoretical physics from the Moscow Institute of Physics and Technology and Ph.D. from the University of Amsterdam.